Literature DB >> 303728

Systemic hypertension associated with coronary artery bypass surgery. Predisposing factors, hemodynamic characteristics, humoral profile, and treatment.

A J Roberts, A P Niarchos, V A Subramanian, R M Abel, S D Herman, J E Sealey, D B Case, R P White, G A Johnson, J H Laragh, W A Gay.   

Abstract

Systemic hypertension occurs in more than one third of patients having coronary artery bypass graft (CABG) operations. This report describes our studies in 100 consecutive patients undergoing CABG. We found that certain preoperative clinical, angiographic, and biochemical factors predispose to the development of perioperative hypertension. These included a well-documented history of hypertension, an elevated blood pressure the day prior to operation, greater than 50 percent obstruction of the left main coronary artery, and increased levels of dopamine beta hydroxylase (DBH). The hemodynamic pattern of perioperative hypertension was that of an increased systemic vascular resistance which was associated with increased levels of plasma catecholamines and plasma renin activity (PRA). Nitroprusside was shown to be effective in managing CABG hypertension, although other, more specific therapy may be preferable.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303728

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Urapidil, sodium nitroprusside and nitroglycerin. Effects on haemodynamics, venous admixture and arterial oxygenation after coronary artery bypass grafting.

Authors:  T Möllhoff; P Rosiers; H van Aken
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Urapidil versus clonidine. Acute haemodynamic effects during control of intraoperative hypertensive episodes.

Authors:  W Hess
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Factors relating to the development of hypertension after cardiopulmonary bypass.

Authors:  T J Cooper; T H Clutton-Brock; S N Jones; J Tinker; T Treasure
Journal:  Br Heart J       Date:  1985-07

4.  Hypertension following coronary artery bypass graft.

Authors:  W McIlvaine; M Boulanger; J G Maillé; B Paiement; J Taillefer; P Sahab
Journal:  Can Anaesth Soc J       Date:  1982-05

5.  Does propranolol alter the vascular response to phenylephrine before or during halothane anaesthesia in patients with coronary artery disease?

Authors:  D F Grum; S S Azmy
Journal:  Can J Anaesth       Date:  1992-01       Impact factor: 5.063

6.  Nifedipine for postoperative blood pressure control following coronary artery vein grafts.

Authors:  V S Iyer; W J Russell
Journal:  Ann R Coll Surg Engl       Date:  1986-03       Impact factor: 1.891

7.  Comparative clinical study of pulsatile and non-pulsatile perfusion in 350 consecutive patients.

Authors:  K M Taylor; W H Bain; K G Davidson; M A Turner
Journal:  Thorax       Date:  1982-05       Impact factor: 9.139

8.  Pathophysiology of hypertension following coronary artery bypass surgery: an experimental dog model for postoperative hypertension.

Authors:  E Yamanouchi; H Maeta; M Hori
Journal:  Heart Vessels       Date:  1985-11       Impact factor: 2.037

9.  Peripheral vascular resistance and angiotensin II levels during pulsatile and non-pulsatile cardiopulmonary bypass.

Authors:  K M Taylor; W H Bain; M Russell; J J Brannan; I J Morton
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

Review 10.  Perioperative hypertension management.

Authors:  Joseph Varon; Paul E Marik
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.